We showed that ASX inhibited the invasion of tumor cells via NF-κB p65 and Wnt/β-catenin by reducing the phosphorylation of GSK-3β (Ser9) in liver oncogenesis [14,26,43,44]. Here, NFKB1 is linked to neoplasm.